Breathe Well Live Well
|
AstraZeneca enters into $232m asthma drug deal with Synairgen
Pharmaceutical Business Review AstraZeneca has entered into a global licence agreement with Synairgen for SNG001, a new, inhaled interferon beta (IFN-beta) being developed for the treatment of respiratory tract viral infections in patients with severe asthma. AstraZeneca … |
View full post on asthma – Google News
|
AstraZeneca licenses experimental asthma drug
Philadelphia Business Journal (blog) AstraZeneca entered into an exclusive global licensing agreement Thursday for an experimental asthma drug being developed by Synairgen, a United Kingdom biopharmaceutical company. Under the terms of the deal, AstraZeneca (NYSE: AZN) will make an … |
View full post on asthma – Google News
Reuters UK |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Fox Business AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest drugmaker – subject of a … AstraZeneca extends global shopping spree with $232M asthma drug deal Synairgen breathes easier with $225M from Astrazeneca for its asthma drug |
View full post on asthma – Google News
|
Exposure to smoke in cars may worsen asthma: study
Business Insider By Mollie Bloudoff-Indelicato. NEW YORK (Reuters Health) – People with asthma may face increased risk from secondhand smoke exposure while riding in the close quarters of a vehicle, according to U.S. researchers. In a survey covering four southern … |
View full post on asthma – Google News
|
Research and Markets: Europeab Asthma Market Highlights – 2014 Report
Business Wire (press release) The latest research, 'Europe Asthma Market Highlights – 2014', provides asthma market analysis, competitive landscape, and asthma drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain … Research and Markets: Japan Asthma Market Report 2014-2019 |
View full post on asthma – Google News
|
Two drugs are better than one for asthma control: study
Business Insider NEW YORK (Reuters Health) – People with asthma are likely to benefit from combining medications to manage their symptoms, a strategy that requires doctors and patients to work together to tweak prescriptions, Dutch researchers say. Based on a review of … |
View full post on asthma – Google News
|
FDA approves Teva's QVAR with dose counter to treat asthma
Pharmaceutical Business Review The US Food and Drug Administration (FDA) has approved the use of Teva Pharmaceutical's QVAR (beclomethasone dipropionate HFA) with a dose counter for the ongoing treatment of asthma as a preventative therapy in patients five years of age and older. |
View full post on asthma – Google News
|
Good asthma management may stave off kids' anxiety
Business Insider NEW YORK (Reuters Health) – Children with asthma are no more likely than their peers to suffer mental health problems – provided their asthma is well-controlled, according to Dutch researchers. “The original literature, mostly from America, suggested … |
View full post on asthma – Google News
Laboratory Equipment |
Study questions role of vitamin D in asthma
Business Insider NEW YORK (Reuters Health) – Giving people with asthma and low vitamin D levels extra doses of the vitamin doesn't do much to help their lungs, a new study suggests. Previous research had linked low vitamin D levels to more asthma-related problems, like … Asthma: vitamin D supplements 'do not improve symptoms or treatment' Vitamin D has Little Benefit as Asthma Treatment Vitamin D Supplements May Not Help Ease Asthma |
View full post on asthma – Google News
|
Doctor: Pittsburgh's asthma rates exceed national average
Pittsburgh Business Times (blog) Pittsburgh's asthma rate exceeds national levels, according to Dr. Deborah Gentile, director of research, allergy, asthma and immunology at Allegheny Health Network. Pittsburgh's asthma rate ranges between 12 percent and 13 percent, which exceeds the … |
View full post on asthma – Google News